![Granions de Chrome 250 µg / jour (60 comprimés) - Halte aux pulsions sucrées - Limite les envies de sucres Granions de Chrome 250 µg / jour (60 comprimés) - Halte aux pulsions sucrées - Limite les envies de sucres](https://medias.ea-pharma.digital/catalog/product/cache/d20e53687d4498a01309e274f2f268e8/c/h/chrome-250_cps_face.png)
Granions Chromium
In stock
Description
Scientific studies demonstrate the effectiveness of Chromium in maintaining blood sugar levels.
As a specialist in trace elements, Laboratoire des GRANIONS has developed Granions de chrome 250 µg/d (2 tablets of 125 µg per day), thus responding to new scientific advances.
What are the benefits?
> Chromium is an essential trace element for the metabolism of macro-nutrients (carbohydrates and lipids). It contributes to the maintenance of normal blood sugar levels.
> Easier to absorb thanks to its small chewable tablets.
> Easy to use: only 2 high dose tablets in the morning. That's all there is to it.
Food supplement with sweetener.
Net weight: 12 g
Box of 60 tablets
30 day programme.
More Information
Ingredients
Ingredients :
Sweetener: sorbitol, anti-caking agents: microcrystalline cellulose - magnesium stearate, natural orange flavour (maltodextrin - gum arabic), chromium picolinate, thickener: cross-linked sodium carboxymethyl cellulose.
Composition in active ingredients :
* RA: Reference Intakes
Directions for use :
Oral way: 2 chewable tablets per day, preferably in the morning on an empty stomach.
Precautions for use:
Do not exceed the recommended dose.
To be used as a food supplement as part of a varied and balanced diet and a healthy lifestyle.
Keep out of reach of young children.
In general, pregnant and breastfeeding women should be advised to consult a health professional before taking any supplements.
Excessive consumption may have laxative effects (sorbitol).
This food supplement is not a medicine.
This product has been developed and manufactured in accordance with the requirements of EN 17444 as of the production date of the batch. Compliance with the standard refers to the implementation of good development and manufacturing practices aimed at preventing the presence of prohibited substances but does not guarantee the absence of such substances. The standard does not constitute approval for use for those subject to anti-doping control.
![Nome AFNOR EN 17444](https://en.eafit.com/static/version1723544157/frontend/Ea/hyva/en_GB/images/normes/afnor-anti-dopage-en-17444.png)